InspireMD's Upcoming Financial Results Announcement
InspireMD, Inc. (NASDAQ: NSPR), known for developing the revolutionary CGuard™ Prime carotid stent system, is gearing up to announce its fourth quarter and full year financial results for 2024. The reveal is scheduled for March 12, 2025, showcasing the company's latest advancements and updates following a productive year.
Conference Call Details
In conjunction with the financial results release, InspireMD will conduct a conference call and a live webcast beginning at 8:30 a.m. Eastern Time. This event aims to provide shareholders and interested parties with an in-depth overview of the company’s financial health and strategic direction. Participants can dial in using designated phone numbers depending on their location.
Accessing the Financial Call
For those who wish to join the live earnings call, domestic callers can connect at 1-800-579-2543, while international attendees should use 1-785-424-1789. Interested parties can also participate through the Events Section of the InspireMD investor relations website.
About InspireMD, Inc.
InspireMD is on a mission to set new benchmarks in the carotid stenting industry through its proprietary MicroNet technology. This innovative approach is designed to ensure patients experience remarkable acute outcomes along with long-lasting, stroke-free results. The company's common stock trades on the Nasdaq under the ticker symbol NSPR, and they consistently engage with investors via their website to keep them informed.
Company Highlights
As InspireMD prepares for the upcoming financial announcement, it's worth noting the company’s commitment to research and innovation in the field of carotid artery disease (CAD). The CGuard™ Prime system, which has received accolades for its design and effectiveness, underscores InspireMD's dedication to advancing medical technology for improved patient care.
Investor Relations and Contact Information
InspireMD encourages investors to stay updated through their dedicated investor relations page, where a wealth of information is available regarding annual reports, press releases, and upcoming events. For any inquiries, investors are welcome to contact Craig Shore, the Chief Financial Officer, at 888-776-6804 or via email.
Frequently Asked Questions
What is InspireMD known for?
InspireMD is recognized for developing the CGuard™ Prime carotid stent system, utilized in treating carotid artery disease.
When will InspireMD announce its financial results?
The financial results for the fourth quarter and full year of 2024 will be announced on March 12, 2025.
How can I access the earnings call?
Interested parties can join the earnings call by dialing specific phone numbers for domestic and international callers, or they can attend via the company’s investor website.
What stock exchange is InspireMD listed on?
InspireMD's common stock is traded on the Nasdaq under the ticker symbol NSPR.
Who can I contact for investor relations?
Craig Shore, the Chief Financial Officer of InspireMD, is available at 888-776-6804 for any investor relations inquiries.